Overall rank by patents
#35,474
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Geno ranks #35,474 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R35474 · US Corporation #35,474 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Genea IP Holdings PTY Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Geno · this assignee
24 score
3D Lighting… · lowest
7 score
What this shows Geno's Innovation Score is 24.3/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Geno LLC is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Geno sits between Genea IP Holdings PTY Limited and Gestion Ultra Internationale Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Genea IP Holdings PTY Limited
7 patents
General Aviation Modifications, Inc.
7 patents
Genetics Research, LLC
7 patents
Genevant Sciences GMBH
7 patents
Gentium S.R.L.
7 patents
Geomec Engineering, Ltd.
7 patents
Geoverse, LLC
7 patents
Gestion Ultra Internationale Inc.
7 patents
Geno LLC
7 patents
What this shows Geno holds 7 patents at rank #35,441, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,441 in granted patent volume.
Other assignees with the most granted patents in Geno's primary technology class.
Geno's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 14th percentile higher than 14% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2016 | 2 | 28.6% |
| 2017 | 2 | 28.6% |
| 2018 | 1 | 14.3% |
Top 10 of 10 technology areas
Overall rank by patents
#35,474
of 49,997 tracked assignees
24.3 out of 100
What to do with this data
Geno LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.